What's Hot

    Life Risk News Volume 2, Issue 5, May 2023 Out Now!

    12 May 2023

    Editor’s Letter – Volume 2, Issue 5, May 2023

    12 May 2023

    Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

    12 May 2023
    Facebook Twitter Instagram
    Instagram LinkedIn Twitter
    Life Risk News
    • Home
    • Features

      Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

      12 May 2023

      Latest Cost of Insurance Litigation Provides Little in the Way of Certainty

      12 May 2023

      Roundtable: UK Pension Risk Transfer Consultants

      12 May 2023

      Q&A: Thomas Deinet, Executive Director, Standards Board for Alternative Investments

      12 May 2023

      Life Settlement Market Trends Solid But Investors Should Look Below The Headline Numbers

      12 May 2023
    • Commentary

      Moderation in All Things

      12 May 2023

      “Bet The Under”: Hedge Fund Manager Makes Costly Mistake

      12 May 2023

      What Investment Risks Impact a Life Settlement Fund Manager’s Returns and How Can These Be Mitigated?

      13 April 2023

      Long COVID and Reinfection Risk

      13 April 2023

      The Impacts of Climate Change on Mortality

      8 March 2023
    • Events
    • Magazine
    Life Risk News
    Home»Magazine»Editor’s Letter: Volume 1, Issue 2, June 2022

    Editor’s Letter: Volume 1, Issue 2, June 2022

    Magazine 8 June 2022Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Editor's letter
    Share
    Twitter LinkedIn Email

    Life Risk News: Volume 1, Issue 2, June 2022

    ESG pervades all areas of finance, and the life risk industry is no exception. But for holders of longevity risk, and in particular life settlement investors, the perception is that they can’t be aligned to the ESG movement. Arguably, those holding that view can’t see the woods for the trees, and so we spoke to Jonas Martenson of Ress Capital, and Rob Haynie of Life Insurance Settlements Inc. to explore this issue in this month’s cover story, Life Settlements Not Such an Unlikely ESG Ally.

    At the onset and during the first few months of the Covid-19 pandemic, one of the many themes to emerge was that of comparing its effect on the population to the 1918 Influenza pandemic or the SARS pandemic of 2003 this was also of particular concern to holders of mortality risk, such as life insurance companies and life contingent structured settlement investors. We spoke to Matthew Edwards of Willis Towers Watson to learn more about the effects of the pandemic in Mortality Risk Holders Thinking About Covid-19 Pandemic Impacts.

    New for this month, and something that you’ll see in future issues of Life Risk News, is a litigation bulletin. These bulletins will examine the outcome of recent litigation in the life risk market, and this month, we have two articles from ArentFox Schiff discussing the outcome of two recent cases in the life settlement market, Estate of Ann Rink, by its Executor, Michael Rink v. VICOF II Trust and Wells Fargo Bank, N.A. and Berkshire Hathaway Life Insurance Company of Nebraska v. Estate of Phyllis M. Malkin.

    The European life insurance market is facing several challenges and opportunities that are going to shape the future of the industry. Chief among these is an aging European population, which is having a polarizing effect on how insurers service their clients, as well as how they win new ones. Peter Manchester of EY discusses some of the immediate challenges that need to be addressed at a much more rapid pace than most retirement-focused companies are used to moving in a commentary article, How To Navigate European Life Insurance and Retirement Trends.

    Another commentary piece this month comes from James W. Maxson of EM3 Law, LLP. Life Settlements Due Diligence: Legal Counsel’s Perspective, sees Maxson explain the characteristics of life settlements that make legal due diligence particularly important for both managers and investors.

    Our Q&A for this issue is with Chris Anderson of EY. Anderson is an actuary, and we spoke to Anderson to learn more about the impact of longevity on insurance companies and capital markets participation in life risk from an actuarial sciences perspective.

    Finally, this month, we go to MedTech. Advancements in technology that are enabling more tailored risk assessment and treatment of the individual will have a profound impact on how companies and investors with exposure to longevity risk price that risk and construct their portfolios. We spoke to Nicola Oliver of Medical Intelligence to ask Why Longevity Investors Should Pay More Attention to Med-Tech Trends.

    As always, if you’re interested in getting in touch, whether that’s with an idea for a topic that you’d like to see covered, or just to offer some feedback, please do so at [email protected] or send a note to the team at [email protected]. In the meantime, on behalf of ELSA, we hope you enjoy this second issue of Life Risk News; click the link below to download the PDF magazine.

    Greg Winterton, Contributing Editor, Life Risk News

    Life Risk News: Volume 1, Issue 2, June 2022

    Editor's Letter Volume 1 Issue 2 - June 2022
    Share. Twitter LinkedIn Email

    Related Posts

    Editor’s Letter – Volume 2, Issue 5, May 2023

    12 May 2023

    Editor’s Letter – Volume 2, Issue 4, April 2023

    14 April 2023

    Editor’s Letter: Volume 2, Issue 3, March 2023

    8 March 2023

    Editor’s Letter: Volume 2, Issue 2, February 2023

    8 February 2023

    Comments are closed.

    Most Popular

    Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

    12 May 2023

    Latest Cost of Insurance Litigation Provides Little in the Way of Certainty

    12 May 2023

    Roundtable: UK Pension Risk Transfer Consultants

    12 May 2023

    Moderation in All Things

    12 May 2023
    Ad

    Your trusted source for capital markets participation in Life Risk

    Twitter Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Life Risk News Copyright Notice
    • Life Risk News’ Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT